Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROXICODONE vs ROZANOLIXIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROXICODONE vs ROZANOLIXIZUMAB: Safety Overview

Metric ROXICODONE ROZANOLIXIZUMAB
Total FAERS Reports 106 303
Deaths Reported 90 9
Death Rate 84.9% 3.0%
Hospitalizations 6 114
Average Patient Age 45.3 yrs 61.3 yrs
% Female Patients N/A 60.9%
Manufacturer N/A UCB, Inc.
Route N/A SUBCUTANEOUS